Regeneron Announces Upcoming 2014 Investor Conference Presentations
TARRYTOWN, N.Y., Feb. 14, 2014
TARRYTOWN, N.Y., Feb.14, 2014 /PRNewswire/ --Regeneron Pharmaceuticals, Inc.
(NASDAQ: REGN) will webcast management presentations at the following investor
o2014 RBC Capital Markets' Global Healthcare Conference at 10:00 a.m.
Eastern Time on Tuesday, February 25, 2014
oCowen and Company 34^th Annual Healthcare Conference at 1:30 p.m. Eastern
Time on Monday, March 3, 2014
oBarclays Global Healthcare Conference at 1:00 p.m. Eastern Time on
Tuesday, March 11, 2014
The sessions may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page. Archived versions
of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, oncology,
rheumatoid arthritis, asthma, and atopic dermatitis. For additional
information about the company, please visit www.regeneron.com.
Manisha Narasimhan, Ph.D. Peter Dworkin
Investor Relations Corporate Communications
SOURCE Regeneron Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.